1,899
Views
20
CrossRef citations to date
0
Altmetric
Letters to the Editor

Ocular Tuberculosis—A Clinical Conundrum

, MD, , FRCS, MMed & , MD
Pages 237-242 | Received 22 Sep 2014, Accepted 04 Nov 2014, Published online: 25 Jun 2015

References

  • Yeh S, Forooghian F, Wong WT, et al. Fundus Autofluorescence Imaging of the white dot syndromes. Arch Ophthalmol. 2010;128:46–56
  • Rathinam SR, Cunningham ET. Infectious causes of uveitis in the developing world. Int Ophthalmol Clin. 2000;40:137–152
  • Ang M, Htoon HM, Chee S-P. Diagnosis of tuberculous uveitis: clinical application of an interferon-gamma release assay. Ophthalmology. 2009;116:1391–1396
  • Abu El-Asrar AM, Abouammoh M, Al-Mezaine HS. Tuberculous uveitis. Int Ophthalmol Clin. 2010;50:19–39
  • Al-Nakeeb Z, Gupta V, Bell C, Woodhead M. Are we missing opportunities to confirm the diagnosis of tuberculosis by microbial culture? Respir Med. 2013;107:2022–2028
  • Biswas J, Shome D. Choroidal tubercles in disseminated tuberculosis diagnosed by the polymerase chain reaction of aqueous humor: a case report and review of the literature. Ocul Immunol Inflamm. 2002;10:293–298
  • Gupta V, Gupta A, Rao NA. Intraocular tuberculosis—an update. Surv Ophthalmol. 2007;52:561–587
  • Vasconcelos-Santos DV, Zierhut M, Rao NA. Strengths and weaknesses of diagnostic tools for tuberculous uveitis. Ocul Immunol Inflamm. 2009;17:351–355
  • Yeh S, Sen HN, Colyer M, et al. Update on ocular tuberculosis. Curr Opin Ophthalmol. 2012;23:551–556
  • Balne PK, Modi RR, Choudhury N, et al. Factors influencing polymerase chain reaction outcomes in patients with clinically suspected ocular tuberculosis. J Ophthalmic Inflamm Infect. 2014;4:10. doi:10.1186/1869-5760-4-10
  • Van Gelder RN. Ocular pathogens for the twenty-first century. Am J Ophthalmol. 2010;150:595–597
  • Dinnes J, Deeks J, Kunst H, et al. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess. 2007;11:1–196
  • Whitworth HS, Scott M, Connell DW, et al. IGRAs—the gateway to T cell based TB diagnosis. Methods. 2013;61:52–62
  • Hong BK, Khanamiri HN, Bababeygy SR, Rao NA. The utility of routine tuberculosis screening in county hospital patients with uveitis. Br J Ophthalmol. 2014;98:1091–1095
  • Kleinert S, Kurzai O, Elias J, et al. Comparison of two interferon-gamma release assays and tuberculin skin test for detecting latent tuberculosis in patients with immune-mediated inflammatory diseases. Ann Rheum Dis. 2010;69:782–784
  • Albini TA, Karakousis PC, Rao NA. Interferon-gamma release assays in the diagnosis of tuberculous uveitis. Am J Ophthalmol. 2008;146:486–488
  • Llorenç V, González-Martin J, Keller J, et al. Indirect supportive evidence for diagnosis of tuberculosis-related uveitis: from the tuberculin skin test to the new interferon gamma release assays. Acta Ophthalmol. 2013;91:e99–e107
  • Sudharshan S, Ganesh SK, Balu G, et al. Utility of QuantiFERON®-TB Gold test in diagnosis and management of suspected tubercular uveitis in India. Int Ophthalmol. 2012;32:217–223
  • Ang M, Wong W, Ngan CCL, Chee S-P. Interferon-gamma release assay as a diagnostic test for tuberculosis-associated uveitis. Eye. 2012;26:658–665
  • Lee Y-M, Park K-H, Kim S-M, et al. Risk factors for false-negative results of T-SPOT.TB and tuberculin skin test in extrapulmonary tuberculosis. Infection. 2013;41:1089–1095
  • Kurup SK, Buggage RR, Clarke GL, et al. Gamma interferon assay as an alternative to PPD skin testing in selected patients with granulomatous intraocular inflammatory disease. Can J Ophthalmol. 2006;41:737–740
  • Modorati G, Berchicci L, Miserocchi E, et al. Clinical application of an in-house ELISPOT assay in patients with suspicious tuberculous uveitis and no signs of active tuberculosis. Eur J Ophthalmol. 2012;22:808–813
  • Itty S, Bakri SJ, Pulido JS, et al. Initial results of QuantiFERON-TB Gold testing in patients with uveitis. Eye. 2008;23:904–909
  • Slater ML, Welland G, Pai M, et al. Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers. Am J Respir Crit Care Med. 2013;188:1005–1010
  • Pai M, Joshi R, Dogra S, et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med. 2006;174:349–355
  • Gaur RL, Pai M, Banaei N. Impact of blood volume, tube shaking, and incubation time on reproducibility of QuantiFERON-TB Gold in-tube assay. J Clin Microbiol. 2013;51:3521–3526
  • Gineys R, Bodaghi B, Carcelain G, et al. QuantiFERON-TB gold cut-off value: implications for the management of tuberculosis-related ocular inflammation. Am J Ophthalmol. 2011;152:433–440.e1
  • Vos AG, Wassenberg MWM, de Hoog J, Oosterheert JJ. Diagnosis and treatment of tuberculous uveitis in a low endemic setting. Int J Infect Dis. 2013;17:e993–e999
  • Gupta V, Gupta A, Rao NA. Intraocular tuberculosis—an update. Surv Ophthalmol. 2007;52:561–587
  • Gupta A, Bansal R, Gupta V, et al. Ocular signs predictive of tubercular uveitis. Am J Ophthalmol. 2010;149:562--570
  • Ang M, Hedayatfar A, Zhang R, Chee S-P. Clinical signs of uveitis associated with latent tuberculosis. Clin Exp Ophthalmol. 2012;40:689–696
  • Nazari Khanamiri H, Rao NA. Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis. Surv Ophthalmol. 2013;58:203–232
  • Cunningham ET, Gupta A, Zierhut M. The creeping choroiditides—serpiginous and multifocal serpiginoid choroiditis. Ocul Immunol Inflamm. 2014;22:345–348
  • Grosse V, Bange FC, Tischendorf J, et al. A mass in the eye. Lancet. 2002;360:922
  • Ang M, Hedayatfar A, Wong W, Chee S-P. Duration of anti-tubercular therapy in uveitis associated with latent tuberculosis: a case-control study. Br J Ophthalmol. 2012;96:332–336
  • Basu S, Das T. Pitfalls in the management of TB-associated uveitis. Eye. 2010;24:1681–1684
  • Zhang M, Zhang J, Liu Y. Clinical presentations and therapeutic effect of presumed choroidal tuberculosis. Retina (Philadelphia, Pa). 2012;32:805–813
  • Bansal R, Gupta A, Gupta V, et al. Tubercular serpiginous-like choroiditis presenting as multifocal serpiginoid choroiditis. Ophthalmology. 2012;119:2334–2342
  • Rosenbaum JT. To be or not TB? Br J Ophthalmol. 2014;98:999--1000. doi:10.1136/bjophthalmol-2014-304883
  • Ganesh SK, Roopleen, Biswas J, Veena N. Role of high-resolution computerized tomography (HRCT) of the chest in granulomatous uveitis: a tertiary uveitis clinic experience from India. Ocul Immunol Inflamm. 2011;19:51–57
  • Mehta S. Patterns of systemic uptake of 18-FDG with positron emission tomography/computed tomography (PET/CT) studies in patients with presumed ocular tuberculosis. Ocul Immunol Inflamm. 2012;20:434–437
  • Doycheva D, Pfannenberg C, Hetzel J, et al. Presumed tuberculosis-induced retinal vasculitis, diagnosed with positron emission tomography (18F-FDG-PET/CT), aspiration biopsy, and culture. Ocul Immunol Inflamm. 2010;18:194–199
  • Doycheva D, Deuter C, Hetzel J, et al. The use of positron emission tomography/CT in the diagnosis of tuberculosis-associated uveitis. Br J Ophthalmol. 2011;95:1290–1294
  • van der Klooster JM, Bosman RJ, Oudemans-van Straaten HM, et al. Disseminated tuberculosis, pulmonary aspergillosis and cutaneous herpes simplex infection in a patient with infliximab and methotrexate. Intensive Care Med. 2003;29:2327–2329
  • Nacci F, Matucci-Cerinic M. Tuberculosis and other infections in the anti-tumour necrosis factor-alpha (anti-TNF-α) era. Best Pract Res Clin Rheumatol. 2011;25:375–388
  • Fonseca JE, Lucas H, Canhão H, et al. Recommendations for the diagnosis and treatment of latent and active tuberculosis in inflammatory joint diseases candidates for therapy with tumor necrosis factor alpha inhibitors: March 2008 update. Acta Reumatol Port. 2008;33:77–85
  • Felber A, Graninger W. Weakly positive tests and chronologic variation of the QuantiFERON assay: a retrospective appraisal of usefulness. Tuberculosis (Edinb). 2013;93:647–653
  • Ramiro S, Gaujoux-Viala C, Nam JL, et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis. 2014. doi:10.1136/annrheumdis-2013-204575
  • Mercadal L, Foltz V, Isnard-Bagnis C, et al. Tuberculosis after conversion from azathioprine to mycophenolate mofetil in a long-term renal transplant recipient. Transplant Proc. 2005;37:4241–4243
  • Skhiri H, Guedri Y, Souani Y, et al. Primary tuberculosis 1 year after conversion from azathioprine to mycophenolate in recipient kidney transplantation: a case report. Transplant Proc. 2003;35:2678–2679

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.